StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 06 - 15
1
2022 - 10 - 19
1
2022 - 09 - 13
1
2022 - 08 - 19
1
2022 - 08 - 15
1
2022 - 07 - 13
1
2022 - 06 - 28
1
2022 - 06 - 07
1
2022 - 04 - 29
1
2022 - 01 - 31
1
2021 - 12 - 31
1
Sector
Health technology
11
Tags
Agreement
2
Alliances
3
Antibody
3
Application
4
Approval
10
Approved
4
Australia
4
Authorization
24
Authorized
5
Awards
3
Biocapital
29
Biopharma
3
Bioscience
2
Biotech
2
Biotechnology
22
Canada
3
Candidate
2
Chmp
3
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
4
Conference
26
Congress
2
Covid
67
Covid-19
93
Deadline
5
Disease
7
Earnings
6
Emergency use authorization
10
Europe
9
Events
9
Fda
11
Financial
10
Financial results
7
Global
3
Grant
5
Granted
8
Grants
3
Health
7
India
10
Influenza
7
License
3
Merge
9
N/a
131
Nuvaxovid
3
Nvx-cov2373
5
Offering
6
People
4
Phase 2
5
Phase 2b
3
Phase 3
13
Positive
6
Product-news
3
Prototype
5
Research
10
Results
27
Submission
5
Switzerland
3
Trial
20
Vaccine
132
World
3
Entities
Novavax, inc.
11
Symbols
ABBV
42
ABT
79
ACER
12
ADMA
18
ALPMF
17
ALPMY
17
AMGN
23
AMRX
15
ANIP
17
APYX
12
AQST
15
ARDX
11
ARVL
10
ATXI
10
BCLI
14
BDX
13
BGNE
16
BIIB
32
BLUE
13
BMRN
10
BMY
20
BNTX
24
BSX
11
CHRS
23
EGRX
11
EYEN
13
FBIO
14
FNCTF
63
GILD
21
GSK
14
INCY
23
IONS
13
JAGX
16
JNJ
225
LLY
71
MDT
28
MESO
15
MRK
36
MRNA
13
NVAX
11
NVO
11
NVS
28
NVSEF
22
OCGN
15
PFE
74
PRGO
90
REGN
50
RETA
12
SNGX
14
SNY
236
SNYNF
204
SRNE
21
TAK
16
TEVJF
22
TMO
16
TNXP
12
TTOO
14
VERU
14
VRCA
13
VRTX
14
Exchanges
Nasdaq
11
Crawled Date
2023 - 06 - 15
1
2022 - 10 - 19
1
2022 - 09 - 13
1
2022 - 08 - 19
1
2022 - 08 - 15
1
2022 - 07 - 13
1
2022 - 06 - 28
1
2022 - 06 - 07
1
2022 - 04 - 29
1
2022 - 01 - 31
1
2021 - 12 - 31
1
Crawled Time
13:20
1
15:20
1
19:00
4
22:00
3
23:00
2
Source
www.biospace.com
2
www.fda.gov
1
www.prnewswire.com
8
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
symbols :
Nvax
save search
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
Published:
2023-06-15
(Crawled : 22:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-50.5%
|
O:
1.74%
H:
1.71%
C:
-1.95%
fda
covid
vaccine
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
Published:
2022-10-19
(Crawled : 15:20)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-78.57%
|
O:
-1.34%
H:
7.24%
C:
-2.4%
covid-19
fda
grants
authorization
FDA Roundup: September 13, 2022
Published:
2022-09-13
(Crawled : 19:00)
- fda.gov
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-87.04%
|
O:
1.2%
H:
5.65%
C:
4.49%
fda
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17
Published:
2022-08-19
(Crawled : 23:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
covid-19
fda
grants
authorization
Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
Published:
2022-08-15
(Crawled : 13:20)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-90.38%
|
O:
2.44%
H:
1.6%
C:
-0.42%
covid-19
fda
application
authorization
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
Published:
2022-07-13
(Crawled : 22:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-94.3%
|
O:
-4.42%
H:
2.36%
C:
-22.79%
covid-19
fda
grants
authorization
emergency use authorization
Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants
Published:
2022-06-28
(Crawled : 23:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-92.19%
|
O:
-2.27%
H:
6.45%
C:
3.91%
covid-19
fda
antibody
meeting
prototype
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
Published:
2022-06-07
(Crawled : 22:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-91.61%
|
O:
10.03%
H:
1.22%
C:
-4.21%
covid-19
fda
vaccine
authorization
order
emergency use authorization
FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine
Published:
2022-04-29
(Crawled : 19:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-90.99%
|
O:
3.79%
H:
14.21%
C:
-1.92%
covid-19
fda
vaccine
review
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
Published:
2022-01-31
(Crawled : 19:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-95.74%
|
O:
4.0%
H:
1.41%
C:
-2.33%
covid-19
fda
covid
authorization
vaccine
merge
emergency use authorization
Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
Published:
2021-12-31
(Crawled : 19:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.42%
|
O:
-2.17%
H:
3.53%
C:
-5.55%
covid-19
fda
application
covid
authorization
vaccine
merge
emergency use authorization
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.